Margaret Chua

The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentary

David L Kok, Annie Wang, Wen Xu, Margaret ST Chua, Alexander Guminski, Michael Veness, Julie Howle, Richard Tothill, Ganessan Kichendasse, Michael Poulsen, Shahneen Sandhu, Gerald Fogarty

Journal article  |  2020  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine tumor of the skin with an estimated disease-associated mortality..

Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma

Christopher P Daniels, Mathias Bressel, June Corry, Aidan Cole, Margaret S-T Chua, Albert Tiong, Nir Hirshoren, Ben Dixon, Lachlan McDowell

Journal article  |  2020  |  PRACTICAL RADIATION ONCOLOGY

PURPOSE: Treatment package time (TPT) prolongation is associated with lower overall survival and locoregional control in mucosal h..

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma

Alison M Weppler, Andrew Pattison, Prachi Bhave, Paolo De Ieso, Jeanette Raleigh, Athena Hatzimihalis, Anthony J Gill, Shiva Balachander, Jason Callahan, Margaret Chua, George Au-Yeung, Grant A McArthur, Rodney J Hicks, Richard W Tothill, Shahneen Sandhu

Conference Proceedings  |  2020  |  JOURNAL FOR IMMUNOTHERAPY OF CANCER

BACKGROUND: Metastatic Merkel cell carcinoma (mMCC) is an aggressive neuroendocrine malignancy of the skin with a poor prognosis. ..

Clinical and FDG-PET markers of immune checkpoint inhibitor (ICI) response in patients with metastatic Merkel cell carcinoma (mMCC).

Alison Weppler, Prachi Bhave, Paolo De Ieso, Jeanette Raleigh, Athena Hatzimihalis, Anthony J Gill, Shiva Balachander, Jason Callahan, Andrew Pattison, Margaret Chua, George Au-Yeung, Grant A McArthur, Rodney J Hicks, Richard Tothill, Shahneen Kaur Sandhu

Conference Proceedings  |  2019  |  JOURNAL OF CLINICAL ONCOLOGY

9540 Background: mMCC is a rare, highly aggressive neuroendocrine cancer with a poor prognosis. ICIs have favourable efficacy and..

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma

J Lewin, L Sayers, D Kee, I Walpole, A Sanelli, L te Marvelde, A Herschtal, J Spillane, D Gyorki, D Speakman, V Estall, S Donahoe, M Pohl, K Pope, M Chua, S Sandhu, GA McArthur, CJ McCormack, M Henderson, RJ Hicks, et al.

Journal article  |  2018  |  ANNALS OF ONCOLOGY

Background: As early detection of recurrent melanoma maximizes treatment options, patients usually undergo post-operative imaging ..